policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
Use of technology in veterinary medicine
The AVMA supports responsible and ethical development and use of technology that can benefit and protect public health, animal health and welfare, and…
policy
Use of prescription drugs in veterinary medicine
Veterinary prescription drugs are those drugs restricted by federal law to use by or on the order of a licensed veterinarian.
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
AVMA news
Artificial intelligence in veterinary medicine: What are the ethical and legal implications?
AVMA Axon recently debuted the webinar "Do No Harm: Ethical and Legal Implications of A.I." by Dr. Dr. Eli Cohen, a clinical professor of diagnostic…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
AVMA news
WVC features AVMA sessions, research results
The AVMA offered sessions at the 2023 WVC Annual Conference as part of a year-old partnership with Viticus Group, the organization that hosts WVC.…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
AASV basic guidelines of judicious therapeutic use of antimicrobials in swine
The American Association of Swine Veterinarians and AVMA both support these guidelines on judicious therapeutic antimicrobial use in pork production.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Convention presenters dispense cannabis updates
Presentations on the research and regulations concerning the use of cannabis in veterinary medicine will be offered throughout the AVMA Virtual…
policy
Therapeutic pet food health claims
The FDA uses enforcement discretion in overseeing certain pet food claims. While many of these could legally be considered drugs, certain claims are…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
The veterinarian-client-patient relationship (VCPR)
The veterinarian-client-patient relationship (VCPR) is the basis for interaction among veterinarians, clients, and patients and is critical to the…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
policy
AAAP guidelines for judicious therapeutic use of antimicrobials in poultry
The AVMA has endorsed these guidelines on judicious therapeutic antimicrobial use in poultry production, developed by the American Association of…
Antimicrobial use and resistance: AVMA policies
Explore AVMA policies related to antimicrobial use in veterinary medicine, including guidelines on judicious therapeutic use, the definition of…
policy
Veterinary ergonomic guidelines
Discover risk factors that could lead to musculo-skeletal injury, examples of related tasks in veterinary medicine, and what to do if you identify a…
policy
Antiparasitic resistance
The AVMA strongly recommends that veterinarians in concert with clients use the most up-to-date guidelines, treatments, and evidence-based medicine…
blog
June webinars: Cannabis use and the state of the equine profession
Cannabis is becoming increasingly available for human recreational and medical use. Should veterinary practices monitor staff use of marijuana and…
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.